Medical Condition News

RSS

LLS awards new SCOR grants valued at $12.5M for research in lymphoma and myeloproliferative neoplasms

The Leukemia & Lymphoma Society (LLS) today announced it has awarded two new Marshall A. Lichtman Specialized Center of Research (SCOR) grants to Frederick W. Alt, Ph.D., Harvard Medical School, and Anthony Green, M.D., Ph.D., University of Cambridge. Each SCOR is valued at $1.25 million a year for five years for a total of $6.25 million.

18 Jul 2011

IHD blood test for Alzheimer's disease yields 83% sensitivity and 82% specificity

Innovative Health Diagnostics (IHD), the innovative company specialising in the development of diagnostic blood tests for Alzheimer's disease and neurodegenerative illnesses presents its first clinical results for its IHD-Amy blood test for Alzheimer's disease.

18 Jul 2011

Scientists identify key immune system regulator in white blood cells

St. Jude Children's Research Hospital scientists provide insight into immune system biology and identify the mechanism that keeps white blood cell activity at a minimum until the specific immune response is needed.

18 Jul 2011

Neutrons show how massive enzyme complexes inside cells control rate of sugar metabolism

Neutrons have shown how massive enzyme complexes inside cells might determine whether sugar is burnt for energy or stored as fat. These findings will improve understanding of diabetes and a range of metabolic diseases.

18 Jul 2011

Brief, intense running doesn't alter kinematics and shock absorption

In competitive runners, a brief, high-intensity run doesn't cause the same kinds of fatigue-related changes in running kinematics and shock absorption as longer training runs, reports a recent issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

18 Jul 2011

Upsher-Smith initiates USL261 ARTEMIS1 Phase III study for seizure clusters in epilepsy patients

Upsher-Smith Laboratories, Inc. announced today the initiation of a Phase III clinical trial to evaluate the safety and efficacy of USL261, an investigational intranasal midazolam, for the rescue treatment of seizures in patients on stable anti-epileptic drug (AED) regimens who require control of intermittent bouts of increased seizure activity, frequently referred to as seizure clusters. USL261 has been granted orphan drug designation for this use by the Food and Drug Administration (FDA).

18 Jul 2011

Endologix, LeMaitre Vascular announce early termination agreement for aortic endovascular products in Europe

Endologix, Inc., developer and marketer of minimally invasive treatments for aortic disorders, and LeMaitre Vascular, Inc., provider of peripheral vascular devices and implants, announced today that the companies have entered into an early termination agreement for LeMaitre's distribution rights of Endologix's aortic endovascular products in Europe.

18 Jul 2011

CSL Behring supports World Federation of Hemophilia with 1 million IUs of von Willebrand factor/Factor VIII

CSL Behring has donated more than 1 million international units (IU) of von Willebrand factor (VWF)/Factor VIII (FVIII) replacement medication to patients through the World Federation of Hemophilia (WFH). The donation supports WFH's progress in improving the diagnosis and treatment of bleeding disorders in developing countries through its Global Alliance for Progress (GAP) program.

18 Jul 2011

Study finds retired football players at higher risk for mild cognitive impairment and Alzheimer's disease

Retired NFL football players are at higher risk for mild cognitive impairment, which can be a precursor to Alzheimer's disease, a Loyola University Health System study has found.

18 Jul 2011

Study: IL-2 monotherapy not effective as maintenance therapy for acute myeloid leukemia

EpiCept Corporation announced today the publication of a new meta-analysis which concluded that interleukin-2 (IL-2) monotherapy is not effective as a maintenance therapy for acute myeloid leukemia (AML) patients in first complete remission. These results were published in the July 7, 2011 edition of Blood, a leading scientific journal in hematology.

18 Jul 2011

Improvement of body image can enhance effectiveness of weight loss programs

Almost a quarter of men and women in England and over a third of adults in America are obese. Obesity increases the risk of diabetes and heart disease and can significantly shorten a person's life expectancy. New research published by BioMed Central's open access journal International Journal of Behavioral Nutrition and Physical Activity shows that improving body image can enhance the effectiveness of weight loss programs based on diet and exercise.

18 Jul 2011

FDA approves Shire's Lialda for maintenance of remission of ulcerative colitis

Shire plc, the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Tablets for the maintenance of remission in patients with ulcerative colitis.

18 Jul 2011

Study: 'The wave of death' may not indicate onset of brain death

The wave-shaped signal, which was previously dubbed 'the wave of death', had already been measured by researchers in Nijmegen in the brains of rats that had just been decapitated. The rats had already had electrodes implanted in their brains before the experiment.

18 Jul 2011

Study reveals far more genetic mutations involved in formation of colon cancer

Researchers at UT Southwestern Medical Center say there are at least 70 genetic mutations involved in the formation of colon cancer, far more than scientists previously thought.

18 Jul 2011

Traumatic brain injury in older veterans increases risk of dementia

Older veterans who experienced traumatic brain injury showed a more than two-fold increase in the risk of developing dementia, according to new research presented today at the Alzheimer's Association® International Conference 2011 (AAIC 2011) in Paris.

18 Jul 2011

Novel compound blocks signaling from protein implicated in many types of cancer

Researchers at New York University's Department of Chemistry and NYU Langone Medical Center have developed a compound that blocks signaling from a protein implicated in many types of cancer. The compound is described in the latest issue of the journal Nature Chemical Biology.

18 Jul 2011

Global research initiatives to standardize Alzheimer's biomarkers

As the Alzheimer's field moves closer to new and earlier tests for the disease, innovative global research initiatives are taking the first important steps to standardize Alzheimer's biomarkers, as evidenced by two presentations made today at the Alzheimer's Association(R) International Conference 2011 (AAIC 2011) in Paris.

18 Jul 2011

Higher rates of falls can occur very early in Alzheimer's disease

Falls are more common among individuals with the earliest signs of Alzheimer's, according to a study presented at the Alzheimer's Association® International Conference 2011.

18 Jul 2011

Information about hazards of unsafe volume levels need to be included with packaging of headphones

Concerned about the potential risk of noise-induced hearing loss that can occur from listening to headphones at high volumes for extended periods of time, members of the American Osteopathic Association's (AOA) House of Delegates voted today that the AOA should advocate for manufacturers to include information about the hazards of unsafe volume levels on or within the product packaging.

18 Jul 2011

AOA supports efforts to prevent traumatic brain injury in athletes

Hoping that amateur and professional sports leagues will follow a path similar to that of the National Football League with its recent tightening of rules surrounding head injuries, members of the American Osteopathic Association's (AOA) House of Delegates voted today to support efforts to prevent traumatic brain injury (TBI) in athletes at the school, sports club, and professional levels.

18 Jul 2011

Medical Condition News

LLS awards new SCOR grants valued at $12.5M for research in lymphoma and myeloproliferative neoplasms

IHD blood test for Alzheimer's disease yields 83% sensitivity and 82% specificity

Scientists identify key immune system regulator in white blood cells

Neutrons show how massive enzyme complexes inside cells control rate of sugar metabolism

Brief, intense running doesn't alter kinematics and shock absorption

Upsher-Smith initiates USL261 ARTEMIS1 Phase III study for seizure clusters in epilepsy patients

Endologix, LeMaitre Vascular announce early termination agreement for aortic endovascular products in Europe

CSL Behring supports World Federation of Hemophilia with 1 million IUs of von Willebrand factor/Factor VIII

Study finds retired football players at higher risk for mild cognitive impairment and Alzheimer's disease

Study: IL-2 monotherapy not effective as maintenance therapy for acute myeloid leukemia

Improvement of body image can enhance effectiveness of weight loss programs

FDA approves Shire's Lialda for maintenance of remission of ulcerative colitis

Study: 'The wave of death' may not indicate onset of brain death

Study reveals far more genetic mutations involved in formation of colon cancer

Traumatic brain injury in older veterans increases risk of dementia

Novel compound blocks signaling from protein implicated in many types of cancer

Global research initiatives to standardize Alzheimer's biomarkers

Higher rates of falls can occur very early in Alzheimer's disease

Information about hazards of unsafe volume levels need to be included with packaging of headphones

AOA supports efforts to prevent traumatic brain injury in athletes

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News